These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 15071769

  • 1. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.
    Benz K, Dötsch J, Rascher W, Stachel D.
    Pediatr Nephrol; 2004 Jul; 19(7):794-7. PubMed ID: 15071769
    [Abstract] [Full Text] [Related]

  • 2. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
    Vivarelli M, Colucci M, Bonanni A, Verzani M, Serafinelli J, Emma F, Ghiggeri G.
    Pediatr Nephrol; 2017 Jan; 32(1):181-184. PubMed ID: 27687621
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
    Sinha A, Bhatia D, Gulati A, Rawat M, Dinda AK, Hari P, Bagga A.
    Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488
    [Abstract] [Full Text] [Related]

  • 4. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
    Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
    [Abstract] [Full Text] [Related]

  • 5. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
    Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM.
    Kidney Int; 2013 Nov 04; 84(5):1025-33. PubMed ID: 23739238
    [Abstract] [Full Text] [Related]

  • 6. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
    Gilbert RD, Hulse E, Rigden S.
    Pediatr Nephrol; 2006 Nov 04; 21(11):1698-700. PubMed ID: 16932900
    [Abstract] [Full Text] [Related]

  • 7. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
    Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
    BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
    [Abstract] [Full Text] [Related]

  • 8. Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?
    Dötsch J, Müller-Wiefel DE, Kemper MJ.
    Pediatr Nephrol; 2008 Jan 30; 23(1):3-7. PubMed ID: 17899207
    [Abstract] [Full Text] [Related]

  • 9. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
    Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM.
    Clin J Am Soc Nephrol; 2016 Apr 07; 11(4):710-20. PubMed ID: 26585985
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
    Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J.
    Nephrol Dial Transplant; 2012 May 07; 27(5):1910-5. PubMed ID: 22076431
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
    Huang J, Du J, Wang S, Xiao L, Zhao X.
    Zhonghua Er Ke Za Zhi; 2014 Jul 07; 52(7):521-4. PubMed ID: 25224058
    [Abstract] [Full Text] [Related]

  • 15. [Management of idiopathic nephrotic syndrome in childhood].
    Peco-Antić A.
    Srp Arh Celok Lek; 2004 Jul 07; 132(9-10):352-9. PubMed ID: 15794060
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.
    Basu B, Mahapatra TK, Mondal N.
    Pediatrics; 2015 Jul 07; 136(1):e132-9. PubMed ID: 26101364
    [Abstract] [Full Text] [Related]

  • 17. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.
    van Husen M, Kemper MJ.
    Pediatr Nephrol; 2011 Jun 07; 26(6):881-92. PubMed ID: 21229269
    [Abstract] [Full Text] [Related]

  • 18. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
    DaSilva I, Huerta A, Quintana L, Redondo B, Iglesias E, Draibe J, Praga M, Ballarín J, Díaz-Encarnación M, Spanish Group for the Study of Glomerular Diseases (GLOSEN).
    BioDrugs; 2017 Jun 07; 31(3):239-249. PubMed ID: 28534103
    [Abstract] [Full Text] [Related]

  • 19. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
    Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.
    Pediatr Nephrol; 2008 Aug 07; 23(8):1269-79. PubMed ID: 18465150
    [Abstract] [Full Text] [Related]

  • 20. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.
    Suri M, Tran K, Sharma AP, Filler G, Grimmer J.
    Int Urol Nephrol; 2008 Aug 07; 40(3):807-10. PubMed ID: 18491215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.